Specific G2 arrest of caprine cells infected with a caprine arthritis encephalitis virus expressing vpr and vpx genes from simian immunodeficiency virus

Virology

Volumn 309, Issue 1, 2003, Pages 41-52

  Bouzar, Amel Baya ^a   Guiguen, François ^a   Morin, Thierry ^a   Villet, Stephanie ^a   Fornazero, Claudie ^a   Garnier, Céline ^a   Gallay, Kathy ^a   Gounel, Françoise ^a   Favier, Colette ^a   Durand, Jitka ^a   Balleydier, Sabine ^a   Mornex, Jean Francois ^a   Narayan, Opendra ^b   Chebloune, Yahia ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

CAEV; Cell cycle; Chimera; Vpr; Vpx

Indexed keywords

DNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPR PROTEIN; VPX PROTEIN; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; CELL CYCLE G2 PHASE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GOAT; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION; SIMIAN IMMUNODEFICIENCY VIRUS; SYNOVIUM; VIRUS GENOME; VIRUS REPLICATION;

CAPRA; CAPRA HIRCUS; CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; LENTIVIRUS; MAEDI-VISNA VIRUS; MAMMALIA; OVIS ARIES; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; VISNA VIRUS;

EID: 12444336971     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00014-X     Document Type: Article

References (58)

1. Arrigo S.J., Chen I.S. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:1991;808-819.
2. Bachand F., Yao X.J., Hrimech M., Rougeau N., Cohen E.A. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. J. Biol. Chem. 274:1999;9083-9091.
3. Barbhaiya R.H., Shukla U.A., Greene D.S. Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment. Eur. J. Clin. Pharmacol. 49:1995;221-228.
4. Bartz S.R., Rogel M.E., Emerman M. Human immunodeficiency virus type 1 cell cycle control Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control . J. Virol. 70:1996;2324-2331.
5. Bieniasz P.D., Cullen B.R. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74:2000;9868-9877.
6. Bukrinsky M., Adzhubei A. Viral protein R of HIV-1. Rev. Med. Virol. 9:1999;39-49.
7. Chebloune Y., Karr B., Sheffer D., Leung K., Narayan O. Variations in lentiviral gene expression in monocyte-derived macrophages from naturally infected sheep. J. Gen. Virol. 77 (Pt. 9):1996;2037-2051.
8. Chebloune Y., Sheffer D., Karr B.M., Stephens E., Narayan O. Restrictive type of replication of ovine/caprine lentiviruses in ovine fibroblast cell cultures. Virology. 222:1996;21-30.
9. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:1990;3097-3099.
10. Cohen E.A., Terwilliger E.F., Jalinoos Y., Proulx J., Sodroski J.G., Haseltine W.A. Identification of HIV-1 vpr product and function. J. Acquir. Immune. Defic. Syndr. 3:1990;11-18.
11. Crawford T.B., Adams D.S., Cheevers W.P., Cork L.C. Chronic arthritis in goats caused by a retrovirus. Science. 207:1980;997-999.
12. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N.R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:1995;7909-7916.
13. Elder R.T., Yu M., Chen M., Zhu X., Yanagida M., Zhao Y. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Weel and Cdc25. Virology. 287:2001;359-370.
14. Elder R.T., Yu M., Chen M., Edelson S., Zhao Y. Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. Virus Res. 68:2000;161-173.
15. Fletcher T.M. III, Brichacek B., Sharova N., Newman M.A., Stivahtis G., Sharp P.M., Emerman M., Hahn B.H., Stevenson M. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J. 15:1996;6155-6165.
16. Fukasawa M., Miura T., Hasegawa A., Morikawa S., Tsujimoto H., Miki K., Kitamura T., Hayami M. Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature. 333:1988;457-461.
17. Gibbs J.S., Lackner A.A., Lang S.M., Simon M.A., Sehgal P.K., Daniel M.D., Desrosiers R.C. Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69:1995;2378-2383.
18. Goh W.C., Rogel M.E., Kinsey C.M., Michael S.F., Fultz P.N., Nowak M.A., Hahn B.H., Emerman M. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat. Med. 4:1998;65-71.
19. Gorrell M.D., Brandon M.R., Sheffer D., Adams R.J., Narayan O. Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes. J. Virol. 66:1992;2679-2688.
20. Guyader M., Emerman M., Sonigo P., Clavel F., Montagnier L., Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 326:1987;662-669.
21. Haase A.T. The pathogenesis of slow virus infections molecular analyses . J. Infect. Dis. 153:1986;441-447.
22. Harmache A., Vitu C., Russo P., Bouyac M., Hieblot C., Peveri P., Vigne R., Suzan M. The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo. J. Virol. 69:1995;5445-5454.
23. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:1995;6705-6711.
24. Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
25. Hoch J., Lang S.M., Weeger M., Stahl-Hennig C., Coulibaly C., Dittmer U., Hunsmann G., Fuchs D., Muller J., Sopper S. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69:1995;4807-4813.
26. Hrimech M., Yao X.J., Branton P.E., Cohen E.A. Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A . EMBO J. 19:2000;3956-3967.
27. Hrimech M., Yao X.J., Bachand F., Rougeau N., Cohen E.A. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J. Virol. 73:1999;4101-4109.
28. Jowett J.B., Planelles V., Poon B., Shah N.P., Chen M.L., Chen I.S. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69:1995;6304-6313.
29. Keppler O.T., Welte F.J., Ngo T.A., Chin P.S., Patton K.S., Tsou C.L., Abbey N.W., Sharkey M.E., Grant R.M., You Y., Scarborough J.D., Ellmeier W., Littman D.R., Stevenson M., Charo I.F., Hemdier B.G., Speck R.F., Goldsmith M.A. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med. 195:2002;719-736.
30. Keppler O.T., Yonemoto W., Welte F.J., Patton K.S., Iacovides D., Atchison R.E., Ngo T., Hirschberg D.L., Speck R.F., Goldsmith M.A. Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 75:2001;8063-8073.
31. Lee M.G., Nurse P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature. 327:1987;31-35.
32. Mahalingam S., Ayyavoo V., Patel M., Kieber-Emmons T., Weiner D.B. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71:1997;6339-6347.
33. Masuda M., Nagai Y., Oshima N., Tanaka K., Murakami H., Igarashi H., Okayama H. Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of weel, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J. Virol. 74:2000;2636-2646.
34. Mselli-Lakhal L., Favier C., Leung K., Guiguen F., Grezel D., Miossec P., Mornex J.F., Narayan O., Querat G., Chebloune Y. Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells. J. Virol. 74:2000;8343-8348.
35. Narayan O., Kennedy-Stoskopf S., Sheffer D., Griffin D.E., Clements J.E. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect. Immun. 41:1983;67-73.
36. Narayan O., Wolinsky J.S., Clements J.E., Strandberg J.D., Griffin D.E., Cork L.C. Slow virus replication the role of macrophages in the persistence and expression of visna viruses of sheep and goats . J. Gen. Virol. 59:1982;345-356.
37. Narayan O., Clements J.E., Strandberg J.D., Cork L.C., Griffin D.E. Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J. Gen. Virol. 50:1980;69-79.
38. Nishino Y., Myojin T., Kamata M., Aida Y. Human immunodeficiency virus type 1 Vpr gene product prevents cell proliferation on mouse NIH3T3 cells without the G2 arrest of the cell cycle. Biochem. Biophys. Res. Commun. 232:1997;550-554.
39. Pancio H.A., Vander H.N., Kosuri K., Cresswell P., Ratner L. Interaction of human immunodeficiency virus type 2 Vpx and invariant chain. J. Virol. 74:2000;6168-6172.
40. Pancio H.A., Vander H.N., Ratner L. The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells. J. Virol. 74:2000;6162-6167.
41. Planelles V., Jowett J.B., Li Q.X., Xie Y., Hahn B., Chen I.S. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70:1996;2516-2524.
42. Poon B., Grovit-Ferbas K., Stewart S.A., Chen I.S. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science. 281:1998;266-269.
43. Re F., Braaten D., Franke E.K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:1995;6859-6864.
44. Rogel M.E., Wu L.I., Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:1995;882-888.
45. Sharp P.M., Bailes E., Stevenson M., Emerman M., Hahn B.H. Gene acquisition in HIV and SIV. Nature. 383:1996;586-587.
46. Silva Teixeira M.F., Lambert V., Mselli-Lakahl L., Chettab A., Chebloune Y., Mornex J.F. Immortalization of caprine fibroblasts permissive for replication of small ruminant lentiviruses. Am. J. Vet. Res. 58:1997;579-584.
47. Singh D.K., Chebloune Y., Mselli-Lakhal L., Karr B.M., Narayan O. Ovine lentivirus-infected macrophages mediate productive infection in cell types that are not susceptible to infection with cell-free virus. J. Gen. Virol. 80 (Pt 6):1999;1437-1444.
48. Spurr N.K., Gough A.C., Lee M.G. Cloning of the mouse homologue of the yeast cell cycle control gene cdc2. DNA Seq. 1:1990;49-54.
49. Stivahtis G.L., Soares M.A., Vodicka M.A., Hahn B.H., Emerman M. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J. Virol. 71:1997;4331-4338.
50. Subbramanian R.A., Cohen E.A. Molecular biology of the human immunodeficiency virus accessory proteins. J. Virol. 68:1994;6831-6835.
51. Tristem M., Marshall C., Karpas A., Hill F. Evolution of the primate lentiviruses evidence from vpx and vpr . EMBO J. 11:1992;3405-3412.
52. Tristem M., Marshall C., Karpas A., Petrik J., Hill F. Origin of vpx in lentiviruses. Nature. 347:1990;341-342.
53. Trono D. When accessories turn out to be essential. Nat. Med. 4:1998;1368-1369.
54. Yang L., Farin C.E. Identification of cDNAs encoding bovine cyclin B and Cdk1/Cdc2. Gene. 141:1994;283-286.
55. Yaniv A., Dahlberg J.E., Tronick S.R., Chiu I.M., Aaronson S.A. Molecular cloning of integrated caprine arthritis-encephalitis virus. Virology. 145:1985;340-345.
56. Yuan X., Matsuda Z., Matsuda M., Essex M., Lee T.H. Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res.Hum.Retroviruses. 6:1990;1265-1271.
57. Zhang L., Huang Y., Yuan H., Tuttleton S., Ho D.D. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology. 228:1997;340-349.
58. Zhao Y., Cao J., O'Gorman M.R., Yu M., Yogev R. Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J. Virol. 70:1996;5821-5826.